Table 3 KD patients with fever duration of 5 or 6 days in the both groups (n = 204)
From: Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea
2000–2004 (n = 100) | 2010–2014 (n = 104) | P | |
|---|---|---|---|
Age (month) | 31.1 ± 22 | 31 ± 20.1 | 0.978 |
Sex (M/F) | 56/44 | 64/40 | 0.477 |
Fever duration (day) | |||
Preadmission | 5.4 ± 0.5 | 5.3 ± 0.4 | 0.047 |
Total | 7.1 ± 1.8 | 6.8 ± 1.5 | 0.104 |
Hospitalization (day) | 8.6 ± 2.8 | 5.8 ± 1.8 | < 0.001 |
Incomplete KD, n (%) | 22 (22) | 46 (44.2) | 0.001 |
Repeated IVIG, n (%) | 7 (7) | 10 (9.6) | 0.615 |
CALs, n (%) | 31(31) | 17 (16.3) | 0.020 |
Eectasia | 29 (29) | 17 (16.3) | 0.044 |
Aneurysm | 2 (2) | 0 (0) | 0.239 |
WBC (/mm3) | 15,500 ± 4800 | 14,800 ± 5100 | 0.318 |
Neutrophil (%) | 65.7 ± 13.7 | 66.8 ± 15.0 | 0.572 |
Lymphocyte (%) | 21.8 ± 11.7 | 23.2 ± 12.6 | 0.407 |
Hemoglobin (g/dL) | 10.7 ± 0.8 | 11.4 ± 0.9 | < 0.001 |
Platelet (x-103/mm3) | 323 ± 125 | 317 ± 78 | 0.038 |
Platelet, follow-up | 532 ± 168 | 407 ± 120 | < 0.001 |
CRP (mg/dL) | 12.5 ± 7.1 | 9.3 ± 6.1 | 0.001 |
ESR (mm/h) | 58 ± 24 | 77 ± 39 | < 0.001 |
Total protein (g/dL) | 6.4 ± 0.6 | 6.4 ± 0.6 | 0.848 |
Albumin (g/dL) | 3.5 ± 0.4 | 3.7 ± 0.4 | 0.002 |
AST (IU/L) | 59 ± 90 | 71 ± 110 | 0.397 |
ALT (IU/L) | 102 ± 125 | 114 ± 177 | 0.570 |
ALT <40 IU, n (%) | 46 (46) | 43 (41.3) | 0.573 |
ALT 41–99 IU, n (%) | 23 (23) | 33 (31.7) | 0.209 |
ALT >100 IU, n (%) | 31 (31) | 28 (26.9) | 0.540 |